{"altmetric_id":13823917,"counts":{"readers":{"mendeley":34,"citeulike":0,"connotea":0},"total":{"posts_count":19},"twitter":{"unique_users_count":17,"unique_users":["SamirNus","KaminskiMed","AndrewHalayko","vinitfll","GarchaMed","davidlederer","PFFORG","NestorMolfino","wasog","LarryR7","cemccarthy02","KarenMa40047396","ISAClinical","pulmonology101","elfarodehuse","ATS_GG","BAMCPulmonary"],"posts_count":18},"facebook":{"unique_users_count":1,"unique_users":["1635858849997667"],"posts_count":1}},"selected_quotes":["Pooled analysis and meta-analysis shows pirfenidone is associated with decreased mortality in IPF #PulmonaryFIbrosis","Not a big fan of meta-analyses but Pirfenidone survival benefit impressive good news for Pulmonary Fibrosis Patients @P\u2026","@cwmclaugh thanks for sharing! How much difference in mortality?","Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in #IPF","@haalarokadia Mortality benefit w Perfenidone #pulmonaryfibrosis"],"citation":{"abstract":"In clinical trials of idiopathic pulmonary fibrosis, rates of all-cause mortality are low. Thus prospective mortality trials are logistically very challenging, justifying the use of pooled analyses or meta-analyses. We did pooled analyses and meta-analyses of clinical trials of pirfenidone versus placebo to determine the effect of pirfenidone on mortality outcomes over 120 weeks.\nWe did a pooled analysis of the combined patient populations of the three global randomised phase 3 trials of pirfenidone versus placebo-Clinical Studies Assessing Pirfenidone in Idiopathic Pulmonary Fibrosis: Research of Efficacy and Safety Outcomes (CAPACITY 004 and 006; trial durations 72-120 weeks) and Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis (ASCEND 016; 52 weeks)-for all-cause mortality, treatment-emergent all-cause mortality, idiopathic-pulmonary-fibrosis-related mortality, and treatment-emergent idiopathic-pulmonary-fibrosis-related mortality at weeks 52, 72, and 120. We also did meta-analyses of these data and data from two Japanese trials of pirfenidone versus placebo-Shionogi Phase 2 (SP2) and Shionogi Phase 3 (SP3; trial durations 36-52 weeks).\nAt week 52, the relative risk of death for all four mortality outcomes was significantly lower in the pirfenidone group than in the placebo group in the pooled population (all-cause mortality hazard ratio [HR] 0\u00b752 [95% CI 0\u00b731-0\u00b787; p=0\u00b70107]; treatment-emergent all-cause mortality 0\u00b745 [0\u00b724-0\u00b783; 0\u00b70094]; idiopathic-pulmonary-fibrosis-related mortality 0\u00b735 [0\u00b717-0\u00b772; 0\u00b70029]; treatment-emergent idiopathic-pulmonary-fibrosis-related mortality 0\u00b732 [0\u00b714-0\u00b776; 0\u00b70061]). Consistent with the pooled analysis, meta-analyses for all-cause mortality at week 52 also showed a clinically relevant and significant risk reduction in the pirfenidone group compared with the placebo group. Over 120 weeks, we noted significant differences in the pooled analysis favouring pirfenidone therapy compared with placebo for treatment-emergent all-cause mortality (p=0\u00b70420), idiopathic-pulmonary-fibrosis-related mortality (0\u00b70237), and treatment-emergent idiopathic-pulmonary-fibrosis-related (0\u00b70132) mortality; similar results were shown by meta-analyses.\nSeveral analytic approaches demonstrated that pirfenidone therapy is associated with a reduction in the relative risk of mortality compared with placebo over 120 weeks.\nF Hoffmann-La Roche\/Genentech.","altmetric_jid":"5225ebc63cf058256d000000","authors":["Steven D Nathan","Carlo Albera","Williamson Z Bradford","Ulrich Costabel","Ian Glaspole","Marilyn K Glassberg","David R Kardatzke","Monica Daigl","Klaus-Uwe Kirchgaessler","Lisa H Lancaster","David J Lederer","Carlos A Pereira","Jeffrey J Swigris","Dominique Valeyre","Paul W Noble","Nathan, Steven D","Albera, Carlo","Bradford, Williamson Z","Costabel, Ulrich","Glaspole, Ian","Glassberg, Marilyn K","Kardatzke, David R","Daigl, Monica","Kirchgaessler, Klaus-Uwe","Lancaster, Lisa H","Lederer, David J","Pereira, Carlos A","Swigris, Jeffrey J","Valeyre, Dominique","Noble, Paul W"],"doi":"10.1016\/s2213-2600(16)30326-5","first_seen_on":"2016-11-19T14:43:10+00:00","funders":["niehs"],"issns":["22132600","2213-2619"],"journal":"The Lancet Respiratory Medicine","last_mentioned_on":1490446264,"links":["http:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600(16)30326-5\/fulltext","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=9&redirect=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flanres%2Farticle%2FPIIS2213-2600%2816%2930326-5%2Ffulltext&code=lancet-site","https:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/27876247\/?i=2&from=nathan%20pirfenidone","http:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600%2816%2930326-5\/fulltext"],"pdf_url":"http:\/\/www.thelancet.com\/article\/S2213260016303265\/pdf","pmid":"27876247","pubdate":"2016-11-01T00:00:00+00:00","publisher":"Elsevier","title":"Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213260016303265","mendeley_url":"http:\/\/www.mendeley.com\/research\/effect-pirfenidone-mortality-pooled-analyses-metaanalyses-clinical-trials-idiopathic-pulmonary-fibro"},"altmetric_score":{"score":10.75,"score_history":{"1y":10.75,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":10.75},"context_for_score":{"all":{"total_number_of_other_articles":8414405,"mean":7.0824487780638,"rank":809984,"this_scored_higher_than_pct":90,"this_scored_higher_than":7599951,"rank_type":"exact","sample_size":8414405,"percentile":90},"similar_age_3m":{"total_number_of_other_articles":282735,"mean":11.843901002355,"rank":40533,"this_scored_higher_than_pct":85,"this_scored_higher_than":241980,"rank_type":"exact","sample_size":282735,"percentile":85},"this_journal":{"total_number_of_other_articles":1019,"mean":21.738872298625,"rank":322,"this_scored_higher_than_pct":68,"this_scored_higher_than":695,"rank_type":"exact","sample_size":1019,"percentile":68},"similar_age_this_journal_3m":{"total_number_of_other_articles":54,"mean":30.211886792453,"rank":13,"this_scored_higher_than_pct":75,"this_scored_higher_than":41,"rank_type":"exact","sample_size":54,"percentile":75}}},"demographics":{"poster_types":{"member_of_the_public":9,"researcher":5,"practitioner":3},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":3,"Scientists":5,"Members of the public":9}},"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":1,"Student  > Doctoral Student":1,"Researcher":5,"Student  > Ph. D. Student":4,"Student  > Postgraduate":5,"Other":9,"Student  > Master":2,"Student  > Bachelor":1,"Lecturer > Senior Lecturer":1,"Professor":3},"by_discipline":{"Medicine and Dentistry":23,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":1,"Computer Science":1,"Unspecified":6,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"twitter":{"IL":1,"US":8,"CA":1,"GB":1,"CO":1,"ES":1},"mendeley":{"DK":1,"BR":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/SamirNus\/statuses\/799986307300728833","license":"gnip","citation_ids":[13823917],"posted_on":"2016-11-19T14:42:53+00:00","author":{"name":"Dr. Samir Nusair, MD","image":"https:\/\/pbs.twimg.com\/profile_images\/546393870867525632\/_HyPLZSA_normal.jpeg","description":"Respiratory Physician: #COPD, #PulmonaryFibrosis #IPF & #Sarcoidosis; Respiratory & #Exercise Physiology\nRT \u2260 Endorsement \n\u05d3\u05e8' \u05e1\u05de\u05d9\u05e8 \u05e0\u05e1\u05d9\u05d9\u05e8","id_on_source":"SamirNus","tweeter_id":"273578159","geo":{"lt":31.78199,"ln":35.21961,"country":"IL"},"followers":624},"tweet_id":"799986307300728833"},{"url":"http:\/\/twitter.com\/KaminskiMed\/statuses\/799992903493783552","license":"gnip","citation_ids":[13823917],"posted_on":"2016-11-19T15:09:05+00:00","author":{"name":"Naftali Kaminski","url":"http:\/\/medicine.yale.edu\/intmed\/pulmonary\/people\/naftali_kaminski-1.profile","image":"https:\/\/pbs.twimg.com\/profile_images\/588167805511438336\/BNGVDL-r_normal.jpg","description":"First Generation Physician-Scientist, & many other things. This account is Private - opinions and tweets do not represent any of the organizations I work with.","id_on_source":"KaminskiMed","tweeter_id":"630713215","geo":{"lt":43.15786,"ln":-71.40562,"country":"US"},"followers":1148},"tweet_id":"799992903493783552"},{"url":"http:\/\/twitter.com\/AndrewHalayko\/statuses\/800006184270987264","license":"gnip","rt":["KaminskiMed"],"citation_ids":[13823917],"posted_on":"2016-11-19T16:01:52+00:00","author":{"name":"Andrew Halayko","image":"https:\/\/pbs.twimg.com\/profile_images\/908154414547877888\/xLcbKcyQ_normal.jpg","description":"Professor, U of Manitoba. Past President Canadian Thoracic Society. Dad, husband, Bombers fan, Jets fan, Moose fan, Winnipeg fan. Views are my own.","id_on_source":"AndrewHalayko","tweeter_id":"4097599278","geo":{"lt":49.8844,"ln":-97.14704,"country":"CA"},"followers":291},"tweet_id":"800006184270987264"},{"url":"http:\/\/twitter.com\/vinitfll\/statuses\/800007704387256320","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-19T16:07:54+00:00","author":{"name":"Vinicio Tafolla","image":"https:\/\/pbs.twimg.com\/profile_images\/748559997898878976\/32Qzonkb_normal.jpg","description":"Neumologo","id_on_source":"vinitfll","tweeter_id":"3226238276","geo":{"lt":null,"ln":null},"followers":195},"tweet_id":"800007704387256320"},{"url":"http:\/\/twitter.com\/GarchaMed\/statuses\/800007909035954176","license":"gnip","citation_ids":[13823917],"posted_on":"2016-11-19T16:08:43+00:00","author":{"name":"Puneet Garcha","url":"http:\/\/www.baylorhealth.com\/Transplant","image":"https:\/\/pbs.twimg.com\/profile_images\/624796247480623104\/0ueom2Uj_normal.jpg","description":"Transplant Pulmonologist. LHR-PHL-CLE-DFW Tweets reflect my personal opinion.","id_on_source":"GarchaMed","tweeter_id":"941472576","geo":{"lt":32.78306,"ln":-96.80667,"country":"US"},"followers":536},"tweet_id":"800007909035954176"},{"url":"http:\/\/twitter.com\/davidlederer\/statuses\/800016102285778944","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-19T16:41:17+00:00","author":{"name":"David Lederer, MD","url":"http:\/\/www.pfdoc.org","image":"https:\/\/pbs.twimg.com\/profile_images\/910115989982871552\/L2KzgkjM_normal.jpg","description":"Associate Professor, Pulmonologist, Epidemiologist @ColumbiaMed, Editor-in-chief @AnnalsATS, @PFFORG #PulmonaryFibrosis My views not CU\/ATS\/PFF, not advice","id_on_source":"davidlederer","tweeter_id":"23368213","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1243},"tweet_id":"800016102285778944"},{"url":"http:\/\/twitter.com\/PFFORG\/statuses\/800039784580321280","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-19T18:15:23+00:00","author":{"name":"PF Foundation","url":"http:\/\/www.pulmonaryfibrosis.org","image":"https:\/\/pbs.twimg.com\/profile_images\/461240017369579521\/HxzeIrYL_normal.jpeg","description":"Pulmonary Fibrosis Foundation. #pulmonaryfibrosis #PFWarrior #BlueUp4PF RT's & Likes \u2260 endorsement","id_on_source":"PFFORG","tweeter_id":"67408662","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":4545},"tweet_id":"800039784580321280"},{"url":"http:\/\/twitter.com\/NestorMolfino\/statuses\/800047752109506560","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-19T18:47:02+00:00","author":{"name":"Nestor A. Molfino","url":"http:\/\/www.drnestormolfino.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3101300457\/2642d057897f3aca8b4b1356c244c13f_normal.jpeg","description":"MD, Pulmonolgist\/Critical Care\/Immunogenetics working in Biotechnology","id_on_source":"NestorMolfino","tweeter_id":"239512569","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":129},"tweet_id":"800047752109506560"},{"url":"http:\/\/twitter.com\/wasog\/statuses\/800051005714997248","license":"gnip","citation_ids":[13823917],"posted_on":"2016-11-19T18:59:58+00:00","author":{"name":"WASOG","url":"http:\/\/www.wasog.org","image":"https:\/\/pbs.twimg.com\/profile_images\/528561184145178625\/BMHCx97L_normal.jpeg","description":"WASOG (World Association for Sarcoidosis and Other Granulomatous Disorders) - Brought to you by Dr. Harry Gosker","id_on_source":"wasog","tweeter_id":"195312146","geo":{"lt":null,"ln":null},"followers":343},"tweet_id":"800051005714997248"},{"url":"http:\/\/twitter.com\/LarryR7\/statuses\/800266672326242304","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-20T09:16:57+00:00","author":{"name":"LarryR","image":"https:\/\/pbs.twimg.com\/profile_images\/709465202182463488\/8CnyacMq_normal.jpg","id_on_source":"LarryR7","tweeter_id":"274578252","geo":{"lt":null,"ln":null},"followers":16},"tweet_id":"800266672326242304"},{"url":"http:\/\/twitter.com\/cemccarthy02\/statuses\/800333012412067840","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-20T13:40:34+00:00","author":{"name":"Claire McCarthy","url":"http:\/\/clairemcomms.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/885516198154309634\/3b8ReNHC_normal.jpg","description":"PhD in Toxicology, fashionista, and reading\/writing enthusiast","id_on_source":"cemccarthy02","tweeter_id":"3294070811","geo":{"lt":39.084,"ln":-77.15276,"country":"US"},"followers":1077},"tweet_id":"800333012412067840"},{"url":"http:\/\/twitter.com\/KarenMa40047396\/statuses\/800385406760079361","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-20T17:08:46+00:00","author":{"name":"Dr Karen Marshall","image":"https:\/\/pbs.twimg.com\/profile_images\/824532766037602305\/StVe9l1R_normal.jpg","description":"Respiratory Nurse Consultant, cognitive behavioural therapist and NIHR Fellow. Passionate about psychological impact of respiratory disease. Loves animals.","id_on_source":"KarenMa40047396","tweeter_id":"4266989417","geo":{"lt":52.16045,"ln":-0.70312,"country":"GB"},"followers":587},"tweet_id":"800385406760079361"},{"url":"http:\/\/twitter.com\/ISAClinical\/statuses\/800527074159038464","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-21T02:31:42+00:00","author":{"name":"ISAClinicalResearch","url":"http:\/\/www.isaclinicalresearch.com","image":"https:\/\/pbs.twimg.com\/profile_images\/716477374532083713\/wSomP7qh_normal.jpg","id_on_source":"ISAClinical","tweeter_id":"716137236253769728","geo":{"lt":null,"ln":null},"followers":13},"tweet_id":"800527074159038464"},{"url":"http:\/\/twitter.com\/pulmonology101\/statuses\/800954796631064576","license":"gnip","rt":["KaminskiMed"],"citation_ids":[13823917],"posted_on":"2016-11-22T06:51:19+00:00","author":{"name":"Carlos Celis","image":"https:\/\/pbs.twimg.com\/profile_images\/883284771522138113\/7du6nIXL_normal.jpg","description":"Pulmonologist, Hospital Universitario San Ignacio. Professor, Faculty of Medicine @UniJaveriana. cacelis.neumo@gmail.com","id_on_source":"pulmonology101","tweeter_id":"771841009","geo":{"lt":4.25,"ln":-74.18333,"country":"CO"},"followers":2356},"tweet_id":"800954796631064576"},{"url":"http:\/\/twitter.com\/pulmonology101\/statuses\/800955849258790912","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-22T06:55:30+00:00","author":{"name":"Carlos Celis","image":"https:\/\/pbs.twimg.com\/profile_images\/883284771522138113\/7du6nIXL_normal.jpg","description":"Pulmonologist, Hospital Universitario San Ignacio. Professor, Faculty of Medicine @UniJaveriana. cacelis.neumo@gmail.com","id_on_source":"pulmonology101","tweeter_id":"771841009","geo":{"lt":4.25,"ln":-74.18333,"country":"CO"},"followers":2356},"tweet_id":"800955849258790912"},{"url":"http:\/\/twitter.com\/elfarodehuse\/statuses\/800962107265216512","license":"gnip","citation_ids":[13823917],"posted_on":"2016-11-22T07:20:22+00:00","author":{"name":"Farmacia Son Espases","url":"http:\/\/www.elcomprimido.com\/FARHSD\/PORTAL.htm","image":"https:\/\/pbs.twimg.com\/profile_images\/588395465592479746\/N5eycZR3_normal.png","description":"Servicio de Farmacia Hospital Son Espases [antes Son Dureta...]","id_on_source":"elfarodehuse","tweeter_id":"3020154741","geo":{"lt":39.56951,"ln":2.64745,"country":"ES"},"followers":1530},"tweet_id":"800962107265216512"},{"url":"http:\/\/twitter.com\/ATS_GG\/statuses\/801197100679598080","license":"gnip","rt":["SamirNus"],"citation_ids":[13823917],"posted_on":"2016-11-22T22:54:08+00:00","author":{"name":"ATS G&G Section","url":"http:\/\/www.thoracic.org\/members\/assemblies\/sections\/gg\/index.php","image":"https:\/\/pbs.twimg.com\/profile_images\/606546353645174786\/x_adTtME_normal.jpg","description":"Official account of American Thoracic Society-Genetics and Genomics Section. Follow us to get updates on 'Omics' in Lung, Critical Care and Sleep medicine.","id_on_source":"ATS_GG","tweeter_id":"3218836586","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":170},"tweet_id":"801197100679598080"},{"url":"http:\/\/twitter.com\/BAMCPulmonary\/statuses\/845619039779127297","license":"gnip","citation_ids":[13823917],"posted_on":"2017-03-25T12:51:04+00:00","author":{"name":"PULM","image":"https:\/\/pbs.twimg.com\/profile_images\/819884909259014145\/xbGKMtl7_normal.jpg","id_on_source":"BAMCPulmonary","tweeter_id":"817732514999570432","geo":{"lt":29.42412,"ln":-98.49363,"country":"US"},"followers":47},"tweet_id":"845619039779127297"}],"facebook":[{"title":"Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1773946276188923&id=1635858849997667","license":"public","citation_ids":[13823917],"posted_on":"2016-11-24T14:00:18+00:00","summary":"\u3000Nathan\u533b\u5e2b\u306e\u8ad6\u6587\u3067\u3059\u3002IPF\u306e\u81e8\u5e8a\u8a66\u9a13\u306f\u6b7b\u4ea1\u7387\u304c\u4f4e\u3044\u305f\u3081\u3001\u6297\u7dda\u7dad\u5316\u85ac\u306e\u6b7b\u4ea1\u7387\u306b\u5bfe\u3059\u308b\u52b9\u679c\u3092\u793a\u3059\u3053\u3068\u306f\u56f0\u96e3\u3068\u8a00\u308f\u308c\u3066\u3044\u307e\u3059\u3002CAPACITY\uff0bASCEND\u306e3\u8a66\u9a13\u306e\u30d7\u30fc\u30eb\u89e3\u6790\u306b\u304a\u3044\u3066\u3001\u30d4\u30eb\u30d5\u30a7\u30cb\u30c9\u30f3\u7fa4\u306f\u30d7\u30e9\u30bb\u30dc\u7fa4\u3088\u308a\u308252\u9031\u6642\u70b9\u3067\u306e\u6b7b\u4ea1\u7387\u306e\u76f8\u5bfe\u30ea\u30b9\u30af\u3092\u6709\u610f\u306b\u6e1b\u5c11\u3055\u305b\u307e\u3057\u305f\uff08\u7dcf\u6b7b\u4ea1\u7387\u30cf\u30b6\u30fc\u30c9\u6bd40.52 [95%\u4fe1\u983c\u533a\u95930.31\u20130.87; p=0.0107]\uff09\u3002\u65e5\u672c\u306eSP2\u3001SP3\u3092\u52a0\u3048\u305f\u30e1\u30bf\u30a2\u30ca\u30ea\u30b7\u30b9\u3067\u3082\u540c\u69d8\u306e\u7d50\u679c\u3067\u3057\u305f\u3002\n\nhttp:\/\/www.thelancet.com\/journals\/lanr","author":{"name":"\u547c\u5438\u5668\u5185\u79d1\u533b","url":"https:\/\/www.facebook.com\/1635858849997667","facebook_wall_name":"\u547c\u5438\u5668\u5185\u79d1\u533b","image":"https:\/\/graph.facebook.com\/1635858849997667\/picture","id_on_source":"1635858849997667"}}]}}